一个单一中心对甲状腺毒性周期性的临床特征进行了回顾性研究
Kota Yamada1,2, Akiyo Tanabe1, Makiko Hashimoto3
1Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
PloS one
|August 1, 2024
概括
甲状腺毒性周期性 (TPP) 是一种罕见的疾病,通常与未被诊断的格雷夫斯病有关. 早期查甲状腺问题对于定期患者的及时治疗至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 内部医学 内部医学
背景情况:
- 甲状腺毒性周期性 (TPP) 呈现肌肉和低血由于转移.
- TPP是罕见的,限制了全面的临床表征.
- 在紧急情况下,区分TPP与其他形式的周期性可能具有挑战性.
研究的目的:
- 为了阐明TPP的临床特征.
- 为了比较TPP患者没有的甲状腺毒性病 (非TPP) 和零星周期性 (SPP).
主要方法:
- 一个单一中心的回顾性队列研究.
- 来自突发性住院的甲状腺功能增高或周期性患者的临床数据的分析.
- 对TPP,非TPP和SPP集团进行比较.
主要成果:
- 与非TPP患者相比,TPP患者更年轻,男性比例更高,BMI更高,血清和水平更低.
- 所有TPP患者都患有Graves病,其中大多数是新诊断的.
- 在关键的临床和实验室参数中,TPP和SPP组之间没有发现显著差异.
结论:
- 在紧急护理中,仅仅根据临床表现区分TPP和SPP是很困难的.
- 未诊断的格雷夫斯病在TPP患者中很常见.
- 建议对甲状腺激素和TSH受体抗体进行查,以早期诊断TPP和开始治疗.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
730
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
730
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K